Quantitative analysis of gene expression using PCR
AssigneePharmagene Laboratories Limited
InventorJanet E. Carey
Life of this patent
Estimating the term…
Abstract
The invention provides an improved method for quantitation of two target genes in a simultaneous PCR, without the need to determine limiting primer concentrations for both targets. In particular, the invention provides a method of quantitation of expression of a first and a second target protein-encoding nucleic acids using a PCR based assay in which amplification of nucleic acid is detected by release of a reporter fluorescent signal which is measured as a nomialized reporter value (“deltaRn”).
Claims6
A method of quantitation of expression of a first and a second target protein-encoding nucleic acids using a PCR based assay in which amplification of nucleic acid is detected by release of a reporter fluorescent signal which is measured as a normalised reporter value (“ΔRn”), the method comprising:
- providing a limiting concentration of a first primer pair, the first primer pair being adapted for amplification of a desired first target, the limiting concentration being selected to provide a first ΔRn value as measured by release of a first fluorescent reporter compound from a first reporter probe;
- selecting a non-limiting concentration of a second primer pair and probe set, the second primer pair being adapted for amplification of a desired second target, the amplification being measured by release of a second fluorescent reporter compound from a second reporter probe, the concentration being selected to provide a second ΔRn value of from three to forty times that provided by said first reporter compound;
- bringing together said first and second primer pairs and probes at their limited and selected concentrations respectively into contact with a sample of nucleic acid;
- performing a polymerase chain reaction under conditions in which the release of the first and second reporter compounds is measured;
- and
- quantitating the amount of first and second target nucleic acids.
Dependencies are inferred from the claim text.